About Contact Us Careers
Sign In

3D Printed Drugs Market Size & Share, by Technology (Inkjet Printing, Zipdose Technology, Stereolithography); Application (Orthopedic, Neurology); End-user (Hospitals, Clinics, Research Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 421
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the 3D Printed Drugs Landscape

top-features-companies
    • Extend Biosciences
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bioduro
    • Affinity Therapeutics
    • Osmotica Pharmaceuticals
    • Acrux
    • Thiomatrix
    • Ico Therapeutics Inc.
    • Formac Pharmaceuticals
    • BiopharmX
    • Pacira Pharmaceuticals Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Pacira Pharmaceuticals Inc and sevredent sourcing solutions partnered to provide exparel to patients undergoing oral and maxillofacial treatments

  • Affinity Therapeutics raised USD 175 million for the development of engineered T cell therapies for cancers that are difficult to treat. The launch is one of the biggest biotech launches of the year.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 421
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising geriatric population, growing prevalence of chronic diseases, along with advantages of 3D printed drugs over general drugs such as low cost and better solubility are the major factors driving the growth of the 3D printed drugs market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033.

Unapproval of 3D printed drugs in many countries and drug shortages due to COVID-19 are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Acrux, Thiomatrix, Ico Therapeutics Inc., Formac Pharmaceuticals, BiopharmX and Pacira Pharmaceuticals Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by technology, application, end user and, by region.

The zipdose segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying